Radiation Oncology
Scope & Guideline
Advancing cancer care through innovative radiotherapy insights.
Introduction
Aims and Scopes
- Clinical Effectiveness and Outcomes Research:
The journal prioritizes studies that assess the effectiveness of various radiation therapy techniques, including comparisons of treatment modalities, patient outcomes, and quality of life metrics. - Technological Innovations in Radiation Therapy:
Research on emerging technologies, such as MRI-guided radiation therapy, proton therapy, and advanced imaging techniques, is a core focus area, facilitating improvements in treatment precision and patient safety. - Personalized and Adaptive Radiation Treatment Planning:
The journal emphasizes the development of personalized treatment plans and adaptive radiation therapy approaches that take into account individual patient characteristics and tumor biology. - Pediatric Radiation Oncology:
Recognizing the unique challenges in treating pediatric patients, the journal includes research focused on radiation therapy protocols, outcomes, and techniques tailored for children. - Integration of Systemic Therapies and Radiation:
Studies exploring the combination of radiation therapy with systemic therapies, such as immunotherapy and targeted therapies, are vital to understanding synergistic effects and improving patient outcomes. - Health Disparities and Access to Care:
The journal seeks to address healthcare disparities in radiation oncology, examining factors that affect access to treatment across diverse populations. - Quality Assurance and Safety in Radiation Therapy:
Research aimed at improving safety protocols, quality assurance measures, and risk management strategies in radiation therapy practices is a significant area of focus.
Trending and Emerging
- Artificial Intelligence and Machine Learning Applications:
There is a growing trend in the use of AI and machine learning to enhance radiation therapy planning, automate contouring, and predict patient outcomes, indicating a shift towards data-driven approaches in clinical practice. - Patient-Reported Outcomes and Quality of Life Assessments:
An increasing emphasis on patient-reported outcomes and quality of life studies reflects a broader trend in healthcare towards prioritizing patient experience and satisfaction in treatment evaluations. - Hypofractionated and Ultra-Hypofractionated Radiation Therapy:
The adoption of hypofractionated and ultra-hypofractionated treatment regimens is on the rise, driven by evidence suggesting comparable or improved outcomes with reduced treatment times. - Integration of Telehealth in Radiation Oncology:
The COVID-19 pandemic has accelerated the integration of telehealth practices in radiation oncology, with increasing research on virtual consultations and remote monitoring of patients. - Focus on Health Disparities and Access to Radiation Therapy:
Emerging themes include a focus on addressing disparities in cancer care, with research aimed at understanding and improving access to radiation therapy for underrepresented and disadvantaged populations. - Multidisciplinary Approaches to Cancer Treatment:
There is a notable trend towards interdisciplinary collaboration, with studies exploring the integration of radiation therapy with surgical, medical, and supportive care to optimize patient outcomes.
Declining or Waning
- Traditional Radiation Techniques:
There has been a noticeable decrease in studies focusing on conventional radiation techniques, such as 2D and 3D conformal radiation therapy, as the field increasingly shifts towards more advanced modalities like IMRT and proton therapy. - Basic Science and Preclinical Studies:
Research articles centered on basic science and preclinical findings related to radiation effects on cellular and molecular levels have become less frequent, with a greater focus now on clinical applications and patient-centered outcomes. - Radiation Therapy Alone Without Concurrent Treatments:
The frequency of studies examining radiation therapy in isolation, without concurrent systemic treatments or multimodal approaches, has declined, reflecting a trend towards integrated treatment strategies. - Historical Perspectives and Case Reports:
The publication of historical analyses and case reports has waned, as the journal increasingly prioritizes larger cohort studies and data-driven research that can provide robust evidence for clinical practices. - Generalized Population Studies:
Research focusing on generalized population trends in radiation therapy usage has decreased, as there is a growing emphasis on personalized medicine and targeted studies that address specific patient demographics or conditions.
Similar Journals
JOURNAL OF RADIATION RESEARCH
Connecting researchers to the latest in radiation science.JOURNAL OF RADIATION RESEARCH, published by Oxford University Press, is a prominent peer-reviewed journal focusing on the diverse fields of radiation science, including health, toxicology, and radiology. Since its inception in 1960, this open-access journal has provided a critical platform for the dissemination of high-quality research, making it accessible to a global audience of researchers, professionals, and students. With a consistent track record, the journal holds an impressive impact factor and is categorized in Q2 of Radiation studies and Q3 in Health and Toxicology as per the 2023 rankings, reflecting its influential role in shaping contemporary discourse in the field. The journal also boasts notable rankings within Scopus, further underscoring its importance in advancing knowledge and innovations related to radiation. Spanning from 1960 to 2024, the JOURNAL OF RADIATION RESEARCH remains at the forefront of scientific exploration and is essential reading for anyone committed to advancing the understanding of radiation and its effects.
ACTA ONCOLOGICA
Advancing the frontiers of cancer research.ACTA ONCOLOGICA is a prestigious multidisciplinary journal published by Medical Journal Sweden AB, dedicated to advancing cancer research and clinical practice. As a key resource in the field of oncology, the journal aims to publish high-quality articles that cover significant developments in cancer biology, treatment modalities, and innovative imaging techniques. With an ISSN of 0284-186X and an E-ISSN of 1651-226X, ACTA ONCOLOGICA operates in the United Kingdom and is recognized for its substantial impact, currently holding a Q2 ranking in the categories of Hematology, Medicine (miscellaneous), Oncology, and Radiology, Nuclear Medicine and Imaging in 2023. The journal’s commitment to disseminating pivotal research is reflected in its inclusion in Scopus, with rankings placing it in the top half of its fields. Though it does not currently offer Open Access, it remains an essential resource for researchers, healthcare professionals, and students seeking to stay informed on the latest trends and findings in oncology. Established in 1963, the journal continues to be a cornerstone of cancer research well into 2024.
Physics & Imaging in Radiation Oncology
Empowering Collaboration in Physics and Imaging for Better Patient CarePhysics & Imaging in Radiation Oncology is a premier journal dedicated to advancing the interdisciplinary field of radiation oncology through innovative research and imaging technologies. Published by Elsevier, this open-access journal has made its mark since its inception in 2017, ensuring that groundbreaking findings are accessible to a broad audience. With a strong focus on the integration of physics, imaging techniques, and oncology, the journal occupies esteemed positions in the academic landscape, ranking in the top quartile for Radiation and Radiology, Nuclear Medicine and Imaging as of 2023. The journal serves as a platform for researchers, professionals, and students to share insights and foster collaboration, ultimately improving patient outcomes through enhanced imaging and treatment modalities. Based in Ireland and operating from Radarweg 29, 1043 NX Amsterdam, Netherlands, the journal aims to bridge the gap between theoretical physics and practical applications in clinical settings.
RADIOTHERAPY AND ONCOLOGY
Elevating hematology and oncology with impactful research findings.Radiotherapy and Oncology is a leading peer-reviewed journal published by Elsevier Ireland Ltd, focusing on the vital fields of hematology, oncology, and radiology. With an impressive impact factor and ranking in the top quartiles (Q1) of its categories as of 2023, it is recognized for disseminating high-quality research that contributes significantly to advancements in cancer treatment and patient care. The journal, which has been in circulation since 1983, aims to provide a platform for original research articles, reviews, and clinical studies that explore the latest innovations in radiotherapeutic technologies and oncology practices. This journal is essential for researchers, healthcare professionals, and students who are dedicated to improving cancer therapies and outcomes. Although it does not offer open access, the wealth of information contained within its pages supports continued education and development in these crucial medical fields.
SEMINARS IN RADIATION ONCOLOGY
Unveiling Breakthroughs in Radiation OncologySEMINARS IN RADIATION ONCOLOGY is a premier journal published by W B SAUNDERS CO-ELSEVIER INC, dedicated to advancing the field of radiation oncology through high-quality research and comprehensive reviews. With an impressive impact factor and a notable HIndex, this journal holds a prominent place within the academic community, particularly illustrated by its Q2 ranking in both Cancer Research and Oncology, and a Q1 ranking in Radiology, Nuclear Medicine, and Imaging as of 2023. Since its inception in 1991, the journal has served as a vital resource for researchers, clinicians, and healthcare professionals, facilitating the exchange of innovative ideas and practices that shape the future of cancer treatment. While the journal is not open access, it offers essential insights into the latest advancements in the field, catering to a diverse audience eager to expand their knowledge and improve patient outcomes in the realm of radiation therapy.
International Journal of Radiation Research
Pioneering Insights in Medical Radiation ApplicationsThe International Journal of Radiation Research, published by the IJRR-IRANIAN JOURNAL RADIATION RES, serves as a critical platform for researchers and professionals in the fields of radiology, nuclear medicine, and imaging technology. Since its inception in 2003, this peer-reviewed, open-access journal has focused on disseminating significant findings and advancements, contributing to the global discourse on radiation research. With an ISSN of 2322-3243, the journal offers valuable insights into emerging technologies and methodologies, maintaining a commitment to enhancing the understanding and application of radiation in medical science. Although currently positioned in the Q4 category across its scopes, the journal strives to elevate its impact by promoting high-quality research and innovative practices. The journal is accessible to a wide audience and encourages submissions from scholars worldwide, directly supporting the advancement of knowledge in radiological and ultrasound technology. For those seeking to explore and contribute to this dynamic field, the International Journal of Radiation Research represents an invaluable resource.
Advances in Radiation Oncology
Transforming Research into Radiotherapy InnovationsAdvances in Radiation Oncology, published by Elsevier Inc, is a premier international journal dedicated to the field of oncology and radiology, focusing on the latest groundbreaking research and innovations in radiation therapy. Launched as an Open Access journal in 2016, it has since carved out a significant niche in the academic community, featuring contributions that span a diverse range of topics including clinical practices, technologies, and outcomes in radiation oncology. With an impressive Q2 rankingOncology and Radiology, Nuclear Medicine and Imaging categories for 2023, and positioned within the 65th and 55th percentiles of Scopus ranks, it serves as an essential resource for researchers, medical professionals, and students alike. The journal not only emphasizes the importance of disseminating knowledge widely through its open access model but also aims to foster collaboration and innovation in the evolving landscape of cancer treatment. For those looking to stay at the forefront of radiotherapy research and advancements, Advances in Radiation Oncology is an invaluable platform for scholarly communication.
MEDICAL PHYSICS
Pioneering Research at the Intersection of Technology and HealthcareMEDICAL PHYSICS, published by WILEY, stands as a leading journal in the fields of biophysics, medicine, and radiology, boasting an impressive impact factor and classified within the prestigious Q1 category across multiple relevant domains. With its ISSN 0094-2405 and E-ISSN 2473-4209, the journal has been a vital resource since its inception in 1974, leading the discourse well into 2024. Hailing from the United States, MEDICAL PHYSICS serves a diverse academic audience, comprising researchers, clinicians, and students eager to engage with the latest advancements and methodologies. The journal’s authoritative presence is underscored by its Scopus rankings, placing it among the top percentile in both Medicine and Biophysics, marking it as an essential scholarly platform for innovative research and critical reviews. While not currently an Open Access journal, its commitment to curating high-quality articles ensures that readers can access groundbreaking insights into medical imaging, treatment protocols, and the theoretical underpinnings of medical physics. Explore the intersection of technology and healthcare through the esteemed pages of MEDICAL PHYSICS.
Journal of Medical Imaging and Radiation Oncology
Fostering Innovation in Imaging for Enhanced Cancer CareJournal of Medical Imaging and Radiation Oncology, published by WILEY, is a pivotal resource in the fields of oncology and medical imaging. With an impact factor reflective of its commitment to advancing research, the journal has maintained a robust reputation since its inception in 2008 and continues to thrive through 2024. It is indexed with an insightful ranking, with a Q2 classification in Radiology, Nuclear Medicine and Imaging, affirming its importance in these disciplines. This journal not only serves as an open access platform, allowing extensive reach and accessibility, but also fosters a scholarly community dedicated to the innovation of imaging techniques and radiation oncology practices. As a key player in disseminating crucial findings and advancements, it appeals to researchers, clinicians, and students who aim to contribute to the evolving landscape of medical imaging and cancer treatment methodologies. The journal is based in Australia, at 111 River St, Hoboken, NJ, and invites submissions that push the boundaries of current knowledge in this critical area of healthcare.
STRAHLENTHERAPIE UND ONKOLOGIE
Connecting researchers to the pulse of cancer therapy advancements.STRAHLENTHERAPIE UND ONKOLOGIE is an esteemed journal published by Springer Heidelberg, focusing on critical advancements and research in the fields of Oncology and Radiology. Established in 1986, this journal has carved its niche within the scientific community, ranking in the Q1 category for Radiology, Nuclear Medicine and Imaging, and Q2 for Oncology as of 2023. With an ISSN of 0179-7158 and E-ISSN 1439-099X, it serves as an essential resource for researchers, professionals, and students dedicated to the complexities of cancer treatment and radiation therapy. While the journal operates under a subscription model, its broad international readership values its rigorous peer-review process and comprehensive coverage of pivotal studies. STRAHLENTHERAPIE UND ONKOLOGIE continues to enhance its impact in the domains of oncology and radiology, as evidenced by its commendable Scopus rankings, including a 76th percentile in Radiology and a 65th percentile in Oncology. Its commitment to disseminating innovative research solidifies its role as a cornerstone in the ongoing quest to improve patient care and therapeutic techniques.